[HTML][HTML] Nitrites in cured meats, health risk issues, alternatives to nitrites: A review
Nitrite is one of the most widely used curing ingredients in meat industries. Nitrites have
numerous useful applications in cured meats and a vital component in giving cured meats …
numerous useful applications in cured meats and a vital component in giving cured meats …
[HTML][HTML] 2018 Guidelines for the management of dyslipidemia in Korea
EJ Rhee, HC Kim, JH Kim, EY Lee… - Journal of lipid and …, 2019 - synapse.koreamed.org
Cardiovascular disease (CVD) is becoming more prevalent worldwide and is one of the
leading causes of death. 1 To lower CVD mortality, aggressive and comprehensive …
leading causes of death. 1 To lower CVD mortality, aggressive and comprehensive …
Fibrates for primary prevention of cardiovascular disease events
T Jakob, AJ Nordmann… - Cochrane Database …, 2016 - cochranelibrary.com
Background Fibrates are effective for modifying atherogenic dyslipidaemia, and particularly
for lowering serum triglycerides. However, evidence that fibrates reduce mortality and …
for lowering serum triglycerides. However, evidence that fibrates reduce mortality and …
[HTML][HTML] The effect of fibrates on kidney function and chronic kidney disease progression: a systematic review and meta-analysis of randomised studies
Aim: Fibrates have proven efficacy in cardiovascular risk reduction and are commonly used,
in addition to statins, to control hypertriglyceridaemia. Their use is often limited due to …
in addition to statins, to control hypertriglyceridaemia. Their use is often limited due to …
[HTML][HTML] Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
C Deerochanawong, SG Kim… - Diabetes & Metabolism …, 2024 - synapse.koreamed.org
Hypertriglyceridemia and decreased high-density lipoprotein cholesterol (HDL-C) persist
despite statin therapy, contributing to residual atherosclerotic cardiovascular disease …
despite statin therapy, contributing to residual atherosclerotic cardiovascular disease …
Haemostatic risk factors in dyslipidemic rabbits: role of 10-dehydrogingerdione as a new hypolipemic agent
MM El-Seweidy, MES Asker, SI Eldahmy… - Journal of thrombosis …, 2015 - Springer
Micro and macrovascular complications occurring during hyperlipidemia are mostly
attributed to haemostatic impairment and vascular endothelial dysfunction. Cholesteryl ester …
attributed to haemostatic impairment and vascular endothelial dysfunction. Cholesteryl ester …
Water extracts of immature Rubus coreanus regulate lipid metabolism in liver cells
B Bhandary, GH Lee, A Marahatta, HY Lee… - Biological and …, 2012 - jstage.jst.go.jp
Hyperlipidemia is a major contributor for atherosclerosis and hypolipidemic drugs such as
statin are highly prescribed to treat elevated lipid level in plasma. Rubus coreanus, which is …
statin are highly prescribed to treat elevated lipid level in plasma. Rubus coreanus, which is …
Effect of statin treatment on homocysteine concentrations: an updated systematic review and meta-analysis with meta-regression
A Zinellu, AA Mangoni - Expert Review of Clinical Pharmacology, 2022 - Taylor & Francis
Background and aims Statins might exert atheroprotective effects through lowering the pro-
atherogenic amino acid homocysteine. We conducted an updated systematic review and …
atherogenic amino acid homocysteine. We conducted an updated systematic review and …
[HTML][HTML] Effect of fenofibrate in 1113 patients at low-density lipoprotein cholesterol goal but high triglyceride levels: Real-world results and factors associated with …
Fibrates are used in patients with dyslipidemia and high cardiovascular risk. However,
information regarding drug response to fibrate has been highly limited. We investigated …
information regarding drug response to fibrate has been highly limited. We investigated …
Rosuvastatin and fenofibrate combination in the treatment of mixed hyperlipidemia: a narrative review
K Biswas, A Tiwari, P Jadhav, A Goel… - Journal of Current …, 2021 - cmro.in
Introduction: Patients with mixed dyslipidemia are presented with high levels of low-density
lipid cholesterol (LDL-C), triglycerides (TG), and reduced high-density lipid cholesterol (HDL …
lipid cholesterol (LDL-C), triglycerides (TG), and reduced high-density lipid cholesterol (HDL …